abstract |
The present invention provides a method of treating cancer using a humanized anti-CD19 (surface antigen classification 19 protein) chimeric antigen receptor. A chimeric antigen receptor (CAR) specific for CD19, a vector encoding the same, and a recombinant T cell comprising CD19 CAR. 【Selection chart】 None |